-
Why metal prices are soaring to record highs
-
Stocks tepid in thin pre-Christmas trade
-
UN experts slam US blockade on Venezuela
-
Bethlehem celebrates first festive Christmas since Gaza war
-
Set-piece weakness costing Liverpool dear, says Slot
-
Two police killed in explosion in Moscow
-
EU 'strongly condemns' US sanctions against five Europeans
-
Arsenal's Kepa Arrizabalaga eager for more League Cup heroics against Che;sea
-
Thailand-Cambodia border talks proceed after venue row
-
Kosovo, Serbia 'need to normalise' relations: Kosovo PM to AFP
-
Newcastle boss Howe takes no comfort from recent Man Utd record
-
Frank warns squad to be 'grown-up' as Spurs players get Christmas Day off
-
Rome pushes Meta to allow other AIs on WhatsApp
-
Black box recovered from Libyan general's crashed plane
-
Festive lights, security tight for Christmas in Damascus
-
Zelensky reveals US-Ukraine plan to end Russian war, key questions remain
-
El Salvador defends mega-prison key to Trump deportations
-
Stranger Things set for final bow: five things to know
-
Grief, trauma weigh on survivors of catastrophic Hong Kong fire
-
Asian markets mixed after US growth data fuels Wall St record
-
Stokes says England player welfare his main priority
-
Australia's Lyon determined to bounce back after surgery
-
Stokes says England players' welfare his main priority
-
North Korean POWs in Ukraine seeking 'new life' in South
-
Japanese golf star 'Jumbo' Ozaki dies aged 78
-
Johnson, Castle shine as Spurs rout Thunder
-
Thai border clashes hit tourism at Cambodia's Angkor temples
-
From predator to plate: Japan bear crisis sparks culinary craze
-
Asian markets mostly up after US growth fuels Wall St record
-
'Happy milestone': Pakistan's historic brewery cheers export licence
-
Chevron: the only foreign oil company left in Venezuela
-
US denies visas to EU ex-commissioner, four others over tech rules
-
Dynamite Blockchain Delivers Record Q3 2025
-
Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy
-
SMX's Integrated Value Proposition: One System, Many Markets, Compounding Leverage
-
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
-
Goldgroup Secures Ownership of the San Francisco Gold Mine Acquiring 100% of Molimentales del Noroeste, S.A. De C.V.
-
Alta Copper Announces Filing and Mailing of Meeting Materials for the Special Meeting of Shareholders and Optionholders to be Held on January 26, 2026
-
Pantheon Resources PLC Announces TR-1: Notification of Major Holdings
-
Bridgeline Expands Footprint with Closeout Retailer Choosing HawkSearch for Its On-Site Search Experience and Personalization
-
Koepka leaves LIV Golf: official
-
US slams China policies on chips but will delay tariffs to 2027
-
Arsenal reach League Cup semis with shoot-out win over Palace
-
Contenders Senegal, Nigeria start Cup of Nations campaigns with wins
-
Tunisia ease past Uganda to win Cup of Nations opener
-
S&P 500 surges to record after strong US economic report
-
UK police say no action against Bob Vylan duo over Israel army chant
-
Libya's top military chief killed in plane crash in Turkey
-
Venezuela passes law to jail backers of US oil blockade
-
French parliament passes emergency budget extension
Trump ties autism risk to Tylenol as scientists urge caution
US President Donald Trump on Monday urged pregnant people not to take Tylenol over an unproven link to autism, and urged major changes to the standard vaccines given to babies.
The announcement comes as the White House has vowed to revolutionize health in the United States, as experts across medicine and science voice broad concern over the administration's initiatives.
Medical professionals have long cited acetaminophen as among the safest painkillers to take during pregnancy, especially as fever and pain can also pose dangers to both the mother and the developing fetus.
But Trump insisted that "taking Tylenol is not good."
"For this reason, they are strongly recommending that women limit Tylenol use during pregnancy unless medically necessary. That's for instance, in cases of extremely high fever that you feel you can't tough it out," he said.
During his news conference Trump then pushed major changes to the routine vaccine schedule given to infants, insisting without evidence that there's "no reason" to vaccinate newborns against the incurable, highly contagious Hepatitis B.
Repeating anti-vaccine movement talking points, Trump said "I would say, wait until the baby is 12 years old and formed."
That statement stands in direct contradiction in the face of broad medical consensus formed over decades that the best way to prevent maternal transmission of the disease that can cause liver damage and cancer is to vaccinate newborns within the first day of life.
His statement comes days after an influential advisory panel handpicked by health chief Robert F. Kennedy Jr. stopped short of advising that a delay of one month of the first dose of Hepatitis B was warranted.
They deemed more discussion was necessary -- offering temporary relief to many experts in public health who said delaying that shot could have dire results.
- New therapy approved -
Identifying the cause of autism -- a complex condition connected to brain development that many experts believe occurs for predominantly genetic reasons -- has been a pet cause of Trump's controversial health chief Robert F. Kennedy Jr.
Earlier this year, Kennedy -- well-known for his anti-vaccine views and penchant for conspiracy theories -- vowed he would release findings regarding autism's cause by September 2025.
The administration's recent initiative to uncover autism's roots has been widely criticized. Kennedy has spent decades pushing discredited claims that link vaccines to autism.
He touted the drug leucovorin, a form of vitamin B first used to alleviate chemotherapy side effects, as an "exciting therapy" that could help children with autism.
The FDA on Monday said it was approving the drug's tablet form to help a subset of children who have "cerebral folate deficiency."
The Trump government's expected focus on acetaminophen, the active ingredient in Tylenol, is likely to meet broad critique.
The American College of Obstetricians and Gynecologists are among the major medical groups who have identified Tylenol as among the safest options for pain relief and fever reduction during pregnancy. Doctors already warn against its long-term use.
Another common over-the-counter pain reliever, ibuprofen, is generally considered unsafe for pregnant people, especially after the 20th week.
- 'Nuanced and uncertain' -
A literature review published last month concluded there was reason to believe a possible link between Tylenol exposure and autism existed -- but other studies have found an opposite result.
Researchers behind the August report cautioned that more study is needed and that pregnant people should not stop taking medication without consulting their doctors.
David Mandell, a psychiatric epidemiologist at the University of Pennsylvania, told AFP that research suggests the possible risks posed by taking Tylenol while pregnant seem "to be lower than the risk of having an uncontrolled infection during pregnancy."
The professor of psychiatry also emphasized that digging into the interaction of genetic and environmental factors is an area of critical research, but that to take on those studies with rigor demands decades of study and funding -- and cast the Trump administration's efforts as rushed.
The Coalition of Autism Scientists earlier called it "highly irresponsible and potentially dangerous to claim links between potential exposures and autism when the science is far more nuanced and uncertain."
"Secretary Kennedy's announcement will cause confusion and fear," said the group in a statement.
J.Oliveira--AMWN